[email protected] (US) / [email protected]    Tel: (781) 999-4286 / (781) 999-5354
Home > CCR


T2375 BX-471 BX471 is a potent, selective non-peptide CCR1 antagonist.
T3188 NSC5844 NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
T3327 Arteether Arteether is a new, fast-acting antimalarial drug.
T3360 ZK 756326 ZK 756326 is a selective, non-peptide CCR8 chemokine receptor agonist (IC50: 1.8μM, in human; 2.6 μM, in mouse). Displays no activity at CCR4/5 and CXCR3/4 a...
T3430 PF-4136309 INCB8761(PF-4136309) is a specific, effective, and orally bioavailable CCR2 antagonist.
T3435 Vicriviroc maleate Vicriviroc maleate(Sch-417690) is a piperazine-based CCR5 receptor antagonist with activity against human immunodeficiency virus. The IC50 value is 0.91 nM in c...
T6016 Maraviroc Maraviroc is a C-C Chemokine Receptor Type 5 (CCR5) antagonist, and for MIP-1α(IC50=3.3 nM), MIP-1β (IC50=7.2 nM) and RANTES(IC50=5.2 nM).Maraviroc inhibits H...
T6413 Bindarit Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
T4300 AZD2098 AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor used for asthma research.
T4584 BMS-813160 BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
T5384 RS 504393 RS 504393 is a highly selective CCR2 chemokine receptor antagonist (IC50s: 89 nM and > 100 μM for human recombinant CCR2 and CCR1).
TQ0103 INCB3344 INCB3344 is an effective, specific and orally bioavailable CCR2 antagonist with IC50 values of 9.5 nM (mCCR2) and 5.1 nM (hCCR2) in binding antagonism and 7.8 n...
TQ0182 MK-0812 MK-0812 is an effective and specific CCR2 antagonist.
TQ0283 RS102895 RS102895 is a potent CCR2 antagonist (IC50: 360 nM) and shows no effect on CCR1.
TQ0297 Cenicriviroc Cenicriviroc is an orally active, dual antagonist of CCR2/CCR5. It also inhibits both HIV-1 and HIV-2, and displays potent anti-infective and anti-inflammatory ...
T7624 DAPTA(TFA) DAPTA(TFA) is an inhibitor of CCR5, shows potent anti-HIV activities.
Prev 1 Next